A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis

Overview of attention for article published in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, March 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Readers on

mendeley: 115 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,035 followers.

17/ A P2 Tirasemtiv P2 Trial for ALS https://t.co/MOzyqScHoO had placebo n=210, age=56.8, time since symptom onset=26.7 months and a -2.4 points change in 12 weeks for a -0.8 change per month.

A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and… https://t.co/GNjNBgNTUu https://t.co/wAwQaXp4YG

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.